Search

Search bills, members, committees and pages...

Sign In

BIOGEN

PreviousNext

20 federal lobbying filings, 2023 to 2026.

BIOGEN is a client on 20 federal lobbying filings, 2023 to 2026, reporting $230K across them. Biotechnology Company Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

3 it has hired, by filings.

RegistrantFilingsReported
BIOGEN15—
THORN RUN PARTNERS4$200K
CLYBURN CONSULTING, LLC1$30K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$2.5M
20254—$4.2M
20244—$4.1M
202310$230K$4.6M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues20
MMMMedicare/Medicaid19
PHAPharmacy15
TAXTaxation/Internal Revenue Code15
TRDTrade (domestic/foreign)14
CPTCopyright/Patent/Trademark10
BUDBudget/Appropriations3
MANManufacturing3
TRATransportation1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…5
S. 832EPIC Act of 20255
H.R. 946ORPHAN Cures Act3
S. 864HELP Copays Act3
H.R. 1262Mikaela Naylon Give Kids a Chance Act2
H.R. 3747Accelerating Access to Dementia and Alzheimer’s Provider Training Act2
H.R. 4317PBM Reform Act of 20252
H.R. 6130ASAP Act2
H.R. 6837To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are con…2
S. 3267ASAP Act2
S. 3345PBM Price Transparency and Accountability Act2
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.1

Lobbyists

Named on the filings.

LobbyistClientsFilings
ALI LAKHANI115
JOHN GIBSON115
JONATHAN CAUSEY115
TYLER HANSON115
DANIEL HARDER111
MATTHEW ITZKOWITZ16
AARON BADIDA15
BEAU SCHUYLER14
GARY PALMQUIST14
KATHLEEN KONKA14
STUART CHAPMAN14
AARON BILL13
BRENDAN WEINTRAUB11
WILLIAM CLYBURN11

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
BIOGENBIOGEN2026 second_quarter$1.1MJul 20, 2026
BIOGENBIOGEN2026 first_quarter$1.5MApr 20, 2026
BIOGENBIOGEN2025 fourth_quarter$770KJan 20, 2026
BIOGENBIOGEN2025 third_quarter$990KOct 20, 2025
BIOGENBIOGEN2025 second_quarter$1.4MJul 20, 2025
BIOGENBIOGEN2025 first_quarter$1MApr 21, 2025
BIOGENBIOGEN2024 fourth_quarter$700KJan 20, 2025
BIOGENBIOGEN2024 third_quarter$710KOct 19, 2024
BIOGENBIOGEN2024 second_quarter$1.7MJul 22, 2024
BIOGENBIOGEN2024 first_quarter$1.1MApr 22, 2024
BIOGENBIOGEN2023 second_quarter$830KFeb 13, 2024
BIOGENTHORN RUN PARTNERS2023 fourth_quarter$50KJan 22, 2024
BIOGENBIOGEN2023 fourth_quarter$940KJan 21, 2024
BIOGENTHORN RUN PARTNERS2023 third_quarter$50KOct 20, 2023
BIOGENBIOGEN2023 third_quarter$1.1MOct 19, 2023
BIOGENBIOGEN2023 second_quarter$790KJul 20, 2023
BIOGENTHORN RUN PARTNERS2023 second_quarter$50KJul 20, 2023
BIOGENBIOGEN2023 first_quarter$990KApr 21, 2023
BIOGENTHORN RUN PARTNERS2023 first_quarter$50KApr 20, 2023
BIOGENCLYBURN CONSULTING, LLC2023 first_quarter$30KApr 18, 2023